Organization | Royal Biological Co., LTD

Royal Biological Co., LTD Report issue

Academic/Hospital Phase 1 Phase 3

Founded: Wuxi China

Organization Overview

First Clinical Trial

2011

NCT01406509

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2012

Timeline

NOW

Now

Alternative names

Royal (Wuxi) Biological Co., LTD

Active Ingredients

Drugs in Phase 3 Trials (3)

a+c+hib conjugate vaccine (2 trials)

hib vaccine (2 trials)

meningococcal a&c vaccine (3 trials)

Drugs in Phase 1 Trials (1)

haemophilus influenzae type b conjugate vaccine (PedvaxHIB) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Haemophilus Infections (Phase 3)

Meningitis (Phase 3)

Overview

Highest Phase: Phase 3
# of Trials: 3
# of Trial APIs: 4